Efficacy and Safety of Levalbuterol in Chronic Obstructive Pulmonary Disease (COPD)

NCT00665600 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

257

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Obstructive Pulmonary Disease (COPD)

Interventions

DRUG: Levalbuterol HCl
DRUG: Levalbuterol HCl
DRUG: Albuterol Sulfate
DRUG: Placebo

Sponsor

Sumitomo Pharma America, Inc.